Gigantism: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 47: | Line 47: | ||
==Case Studies== | ==Case Studies== | ||
[[Gigantism case study one|Case #1]] | [[Gigantism case study one|Case #1]] | ||
==Related Chapters== | ==Related Chapters== | ||
| Line 55: | Line 53: | ||
*[[Local gigantism]] | *[[Local gigantism]] | ||
*[[Overgrowth syndrome]] | *[[Overgrowth syndrome]] | ||
{{Endocrine pathology}} | {{Endocrine pathology}} | ||
Revision as of 15:15, 19 September 2012
| Gigantism | |
 | |
|---|---|
| Anna Haining Bates with her parents | |
| ICD-10 | E22.0, E34.4 |
| ICD-9 | 253.0 |
| DiseasesDB | 30730 |
| MedlinePlus | 001174 |
| MeSH | D005877 |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Gigantism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gigantism On the Web |
|
American Roentgen Ray Society Images of Gigantism |
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gigantism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | EKG | X ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters
de:Riesenwuchs et:Gigantism el:Γιγαντισμός eu:Erraldoitasun id:Gigantisme it:Gigantismo he:ענקיות sr:Gigantizam fi:Jättikasvu sv:Gigantism Template:WH Template:WS